Skyrizi vs Ilumya. What’s the difference?
Both Skyrizi and Ilumya are IL-23 monoclonal antibodies that may be given for the treatment of moderate to severe plaque psoriasis. There are several differences between them:
- Ilumya was FDA approved in 2018 and Skyrizi was FDA approved in 2019
- Ilyumya is a brand name for tildrakizumab and Skyrizi is a brand name for risankizumab
- The dose of Skyrizi is 150mg, but because each injection only contains 75mg, two injections must be given per dose. The dose of Ilumya is 100mg, and each injection contains 100mg therefore only one injection needs to be given each time
- Ilumya needs to be administered by a health care professional; however, patients prescribed Skyrizi can be taught how to self-administer it at home
- Skyrizi is also approved to treat adults with active psoriatic arthritis (PsA), Crohn's disease, and ulcerative colitis.
Comparative trials comparing Skyrizi to Ilumya are lacking; however, a trial that compared Skyrizi to Stelara showed that it has a fast onset of action with 44% of participants achieving PASI 90 by week four compared with only 19% of those administered Stelara.
There are several similarities between Skyrizi and Ilumya:
- Both are approved for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy
- Both Skyrizi and Ilumya are dosed every 12 weeks after an initial loading dose period
- Either may be given as monotherapy or in addition to other therapies
- Side effects are similar.
References
- Skyrizi Injection (risankizumab-rzaa) 06/2024. AbbVie Inc. https://www.rxabbvie.com/pdf/skyrizi_pi.pdf
- Ilumya (tildrakizumab-asmn) 04/2024. Sun Pharmaceutical Industries, Inc. https://www.drugs.com/pro/ilumya-injection.html
Read next
Who is the actress in the Skyrizi commercial?
The actress featuring in the Skyrizi commercials, “Day in the City” and “Downtown Getaway”, first aired on October 12, 2021, is Dana Deggs, born February 9th 1996 in Miami, Florida, USA. She has also appeared in several movies, notably Due Diligence (2008), Class Act (2010) and The Naked Brothers Band (2007). Continue reading
What are Monoclonal Antibodies and how do they work?
Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis.
Continue reading
What are IL-23 Inhibitors and how do they work?
IL-23 inhibitors represent a class of biologic medications that target interleukin-23 (IL-23), a key inflammatory cytokine that plays a central role in driving immune system dysfunction.
Continue readingSee also:
Related medical questions
- What's the dosing schedule for Skyrizi?
- Does Skyrizi cause cancer?
- Can you drink alcohol while taking Skyrizi?
- Who makes Skyrizi and where is it made?
- Skyrizi vs Humira for plaque psoriasis - How do they compare?
- Is Omvoh the same as Skyrizi?
- Does Skyrizi cause hair loss?
- Is Skyrizi approved for treating psoriatic arthritis?
- What are the new drugs for plaque psoriasis?
- How long does it take for Skyrizi to work?
- What causes Plaque Psoriasis?
- Who sings the Skyrizi song ‘Nothing is everything’?
- How does Skyrizi work (MOA)?
- How is Skyrizi injection administered?
- Does Ilumya treat psoriatic arthritis?
- How does Ilumya compare to other treatments?
- How does Ilumya work to treat psoriasis?
- How long does it take Ilumya to work?
- How does Ilumya affect my immune system?
- What are the side effects of Ilumya?
- How is Ilumya administered?
Drug information
Related support groups
- Skyrizi (19 questions, 9 members)
- Ilumya (10 questions, 3 members)
- Risankizumab (9 questions, 3 members)
- Tildrakizumab (7 questions, 3 members)
- Plaque Psoriasis (96 questions, 69 members)